The Legality of Online Anonymity: Two Cases

The Ontario Superior Court of Justice recently released two decisions, one last month and one last week, on the issue of online anonymity, tackling that delicate balance between competing privacy interests, the public interest of promoting justice by facilitating the prosecution of defamation and the underlying values of freedom of expression. Read the rest of this entry »

Do the copycat Apple stores in China harm Apple?

News of fake Apple stores in China sparked a media frenzy last month, with calls of massive intellectual property infringement. Of the five fake stores in Kunming, two were shut down, but for lacking official business licenses, not for who they were pretending to be. More interestingly, according to reports, the Apple products sold at these stores were the real deal. That these stores were and are selling real Apple products complicates the question of whether there are legal claims to be had for copyright infringement. Read the rest of this entry »

Ghost Authorship of Medical Articles Considered Fraud

An article published yesterday in PLoS Medicine, and first presented at an event hosted by the CILP, by Professors Simon Stern and Trudo Lemmens has been receiving considerable media attention. Titled “Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles“, Stern and Lemmens argue that “guest authorship is a disturbing violation of academic integrity standards, which form the basis of scientific reliability.” They continue, “The false respectability afforded to claims of safety and effectiveness through the use of academic investigators risks undermining the integrity of biomedical research and patient care.”

Read the rest of this entry »

Beyond Refusal to Deal: A Cross-Atlantic View of Copyright, Competition and Innovation Policies

Paul-Erik Veel and Professor Ariel Katz have recently released a paper comparing the Competition Law in the European Union and the United States. The abstract:

Conventional wisdom holds that the European Union, through the application of its competition law, has opted to subordinate intellectual property rights in the pursuit of competitive markets to a much greater extent than has the United States. We argue that, at least in the context of copyright protection, this conventional wisdom is false. Read the rest of this entry »

Peanuts and Ponies and Parodies! Oh My!

Generally and theoretically, ‘fair dealing’ in Canada, or ‘fair use’ in the U.S., is meant to foster creativity and innovation, to be a limitation and exception to the copyright holder’s exclusive rights. When it comes to applying fair dealing/use to parodies, however, the exception becomes murky.

A Tumblr blog, “Peanutweeter”, used to have thousands of people following their juxtaposition of classic “Peanuts” cartoons with unrelated, and less innocent, tweets. Unamused, Iconix Brand Group, joint copyright holders with the heirs of creator Charles Schulz, claimed copyright infringement, issued a takedown order and the blog was shut down in June. Read the rest of this entry »

Prof Geist’s FAQ on Opting-Out of Access Copyright

With many Canadian universities opting-out of the Access Copyright interim tariff, I have been receiving a growing number of questions and emails from faculty members at schools across the country inquiring about the implications of the opt-out. All universities should be updating their faculty and students on the copyright changes including why the changes are occurring and what they will mean for research and teaching.  - Professor Michael Geist Read the rest of this entry »

Universities Beginning to Turn to “Tech Savvy Course Alternatives”

If you have been following the Access Copyright issue in Canada, you will know that many Canadian universities have recently pulled out of the Access Copyright licensing scheme, turning instead, to what Prof Geist calls “a most flexible, tech savvy alternative” for course materials. Read the rest of this entry »

Patent Troll on Steroids: How America’s Patent System May Hurt Innovation

This American Life (TAL) is running a story this week that is well worth tuning in for. Some may have heard of Nathan Myhrvold during his time as IBM’s chief strategist and chief of technology or from his $600, six-volume cookbook. But few outside IT circles would know of his “innovative invention company” Intellectual Ventures, and how it is regarded by many in the field as the leader of patent trolls, having amassed roughly 35,000 patents since its inception in 2000. Read the rest of this entry »

Entire Apple Store Knockoffs in China

Fake Louis Vuitton handbags, fake Thomas the Tank Engine toy trains and fake electronics have, in essence, become the norm in China. But the recent incident takes piracy to a whole new level: fake Apple stores in Kunming, a city in the southern Yunnan province.  Read the rest of this entry »

Pfizer v. Ratiopharm: Invalid Patent Insufficient to Support Back-Claim Compensation

Generic drug companies have suffered a setback in the fight to claim compensation when they have been incorrectly kept off the market. The Federal Court of Appeal has refused to overturn a prohibition order against Ratiopharm, thereby disallowing Ratiopharm’s compensation claim, in spite of the fact that Pfizer’s patent is invalid.

Pfizer was initially successful in preventing the invalidation their Patent No. 1,321,393 (‘393 Patent) under the NOC Regulations. Then in 2006, Ratiopharm had another go at Patent ’393 and it was subsequently found that Pfizer had wilfully relied on fraudulent material in support of their patent. This allowed Ratiopharm to then market its generic version of Pfizer’s drug NORVASC. Read the rest of this entry »